March 19, 2017
Einstein Choice shows rivaroxaban effect in recurrent venous thromboembolism
Bayer AG and Janssen Pharmaceuticals reported results from a study called Einstein Choice on Saturday.
Pharmaceuticals, Biotechnology and Life Sciences
Bayer AG and Janssen Pharmaceuticals reported results from a study called Einstein Choice on Saturday.